ConvaTec Stock - Sunday background on business and recent milestones
Published on 06/21/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 08:15 UTC. Details in the imprint.
ConvaTec (GB00BD3VFW73) is a UK-based medical products company specializing in chronic care therapies across advanced wound care, ostomy care and infusion devices. With no fresh market-moving headlines on Sunday, the focus turns to the company’s business profile and recent milestones based on public filings and exchange data.
All news and key data on ConvaTec stock
Background reports, regulatory updates and market data on ConvaTec stock are bundled in the dedicated topic section and on the company’s own investor-relations pages.
How ConvaTec is positioned
ConvaTec operates four main franchises: Advanced Wound Care, Ostomy Care, Infusion Care and Continence & Critical Care, with a focus on chronic conditions that require ongoing treatment and supplies, according to the company’s latest annual report. Company reporting outlines these franchises.
The group generates most of its revenue from hospital and homecare channels in Europe and North America, complemented by growing positions in selected emerging markets. Management highlights aging populations and rising chronic-disease incidence as structural demand drivers for its portfolio.
Recent dividend and trading snapshot
On the London Stock Exchange, ConvaTec shares trade under the ticker CTEC, with a market capitalization around GBP 4.0 billion and a price-to-earnings ratio in the mid-teens, based on recent quote data from a UK broker portal. Hargreaves Lansdown lists market cap and valuation.
The company paid a cash dividend of GBP 0.04 per share with an ex-dividend date of 04/16/2026 and payment on 05/28/2026, corresponding to a dividend yield of about 2.6% at recent prices on the London market. Dividend details are shown in the broker data.
What the company sells
ConvaTec makes money primarily by manufacturing and distributing advanced wound dressings, ostomy bags and accessories, infusion sets and continence-care products that are reimbursed by healthcare systems and insurers, typically on a recurring basis due to chronic patient needs.
Where the stock trades today
The shares of ConvaTec (GB00BD3VFW73) most recently traded around 206.00 pence on the London Stock Exchange, corresponding to a market value near GBP 4.05 billion as of 06/19/2026, 16:35 BST based on exchange-related quote data.
Key facts on ConvaTec stock
- Company: ConvaTec Group Plc
- ISIN: GB00BD3VFW73
- WKN: A2DRJV
- Ticker: CTEC
- Venue: London Stock Exchange
- Price (as of 06/19/2026, 16:35 BST): 206.00 pence (GBP)
- Market cap: 4.05 billion GBP (as of 06/19/2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: FTSE 250
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
